Ob/Gyn & Women's Health Knowledge & Practice

• 10.50 90.50
  Key Advances in Optimizing Outcomes in HR+/HER2- Early Breast Cancer: Straight From The European Oncology Congress
  Medscape Education Oncology December 01, 2023
  Did you know that adding a CDK 4/6 inhibitor to adjuvant endocrine therapy improves overall outcomes in HR-positive/HER2-negative early breast cancer?
  
  0.50 CMEMIN 0.50 ABIM MOCMIN

  
  Save
• 10.50 90.50 20.50
  Tackling Cardiovascular Risks: Strategies to Step Up Your Primary Prevention Game
  Medscape Education Ob/Gyn & Women's Health December 01, 2023
  Dr Bond reviews sex-specific risk factors, treatment, and monitoring strategies to reduce cardiovascular risk in women.
  
  0.50 CME/CEMIN 0.50 ABIM MOCMIN 0.50 CEMIN

  
  Save
• 10.50 20.50
  Talking to Your Patients About Contraception: Meeting Patients' Reproductive Health Goals
  Medscape Education Ob/Gyn & Women's Health November 29, 2023
  Patty Cason discusses empowering women in contraceptive care decision making.
  
  0.50 CME/CEMIN 0.50 CEMIN

  
  Save
• 10.25 90.25 20.25
  Revolutionizing Maternal Health Care: Novel Tools to Address Fetal-Maternal Health Disparities
  Medscape Education Ob/Gyn & Women's Health November 28, 2023
  Dr Merriam discusses strategies and novel tools to integrate into practice to address the maternal health crisis in the United States.
  
  0.25 CME/CEMIN 0.25 ABIM MOCMIN 0.25 CEMIN

  
  Save
• 11.50 21.50
  Disorders of Hair, Pigmentation, and Nails
  Medscape Education Dermatology November 28, 2023
  Don't miss out on key updates from expert faculty!
  
  1.50 CME/CEMIN 1.50 CEMIN

  
  Save
• 10.50 20.50
  What Does It All Mean for Your Practice? Closing Remarks From the Conference Chairs
  Medscape Education Ob/Gyn & Women's Health November 28, 2023
  Drs Nelson and Taylor discuss the key takeaways from all the presentations in the Women’s Health Master Class.
  
  0.50 CME/CEMIN 0.50 CEMIN

  
  Save
• 10.50 90.50 20.50
  Game Changers for Menopausal Patients: New Agents, New Approaches for Vasomotor Symptoms
  Medscape Education Ob/Gyn & Women's Health November 27, 2023
  Dr Santoro discusses the management of vasomotor symptoms in menopausal women.
  
  0.50 CME/CEMIN 0.50 ABIM MOCMIN 0.50 CEMIN

  
  Save
• 10.50 20.50
  Balancing Act: Optimizing Estradiol Ranges for Patients With Uterine Fibroids and Endometriosis
  Medscape Education Ob/Gyn & Women's Health November 27, 2023
  Dr Al-Hendy discusses management of patients with uterine fibroids and endometriosis.
  
  0.50 CME/CEMIN 0.50 CEMIN

  
  Save
• 11.00
  Across the Spectrum: Transforming the Detection and Management of Disease Transitions in Multiple Sclerosis
  November 21, 2023
  This activity follows multiple patient cases from preclinical all the way through late secondary progressive MS. Strategize next steps with MS specialists at each key transition.
  
  1.00 CMEMIN

  
  Save
• 10.50 90.50
  Irritable Bowel Syndrome: Can You Manage These Patients?
  Medscape Education Gastroenterology November 13, 2023
  Are you up to the challenge of managing irritable bowel syndrome (IBS) patients in your practice?
  
  0.50 CMEMIN 0.50 ABIM MOCMIN

  
  Save
• 10.50 90.50 20.50
  Treatment Augmentation in Major Depressive Disorder: Expert Insights on Real-World Considerations
  Medscape Education Psychiatry & Mental Health November 10, 2023
  An expert panel discusses strategies to improve symptoms in patients with inadequate or partial response to initial antidepressant treatment.
  
  0.50 CME/CEMIN 0.50 ABIM MOCMIN 0.50 CEMIN

  
  Save
• 11.25 91.25 21.25
  Congenital Cytomegalovirus: Overcoming Challenges in Identification, Awareness, and Reducing Risk
  Medscape Education Infectious Diseases November 08, 2023
  Even though congenital cytomegalovirus (CMV) is the leading cause of infectious birth defects, awareness is low and challenges exist from diagnosis to management.
  
  1.25 CME/CEMIN 1.25 ABIM MOCMIN 1.25 CEMIN

  
  Save
• 10.75 90.75 20.75
  Congenital Cytomegalovirus: Looking Toward the Future
  Medscape Education Infectious Diseases October 31, 2023
  Where Are We Now With Congenital Cytomegalovirus? Burden, Awareness, and Management
  
  0.75 CME/CEMIN 0.75 ABIM MOCMIN 0.75 CEMIN

  
  Save
• 10.25 90.25
  Are You Up to Date With the Latest Recommendations for Managing Patients With HR-Positive/HER2-Negative Early Breast Cancer?
  Medscape_Education_No_Bots October 25, 2023
  Test your knowledge of best practices for treatment of hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-negative early breast cancer.
  
  0.25 CMEMIN 0.25 ABIM MOCMIN

  
  Save
• 10.75 90.75 20.75
  Accessible Fertility Care: Breaking the Silence on Infertility
  Medscape Education Ob/Gyn & Women's Health October 20, 2023
  How do you engage patients in conception counseling and fertility care?
  
  0.75 CME/CEMIN 0.75 ABIM MOCMIN 0.75 CEMIN

  
  Save
• 10.25 90.25
  Mismatch Repair-Deficient Solid Tumors: Underscoring Key Topics for Care
  Medscape Education Oncology October 13, 2023
  Did you know that immunotherapies demonstrate durable efficacy in patients with mismatch repair deficiency (dMMR) across tumor types?
  
  0.25 CMEMIN 0.25 ABIM MOCMIN

  
  Save
• 11.00 91.00
  Implementing Therapeutic Intervention in High-Risk, HR-Positive/HER2-Negative Early Breast Cancer: Understanding the Prognostic Implications
  Medscape Education Oncology September 29, 2023
  What recommendations do you make for patients with borderline risk of recurrence in the curative setting?
  
  1.00 CMEMIN 1.00 ABIM MOCMIN

  
  Save
• 10.25 20.25
  Episode 3: Diagnosing Congenital CMV and Evaluating Risk of Maternal-Fetal Transmission
  Medscape Education Ob/Gyn & Women's Health September 26, 2023
  Do you know how to assess the risk of a fetus being infected with congenital cytomegalovirus (CMV)?
  
  0.25 CME/CEMIN 0.25 CEMIN

  
  Save
• 10.50 90.50 20.50 30.50
  Hidden in Plain Sight: Anticholinergic Burden in Patients With Overactive Bladder
  Medscape Education Urology September 25, 2023
  Did you know that overactive bladder (OAB) affects approximately 35 million people in the United States and negatively impacts psychosocial functioning and quality of life?
  
  0.50 CME/CEMIN 0.50 ABIM MOCMIN 0.50 CEMIN 0.50 CEMIN

  
  Save
• 20.50
  Optimizing Treatment of Iron Deficiency in Women: Tolerable Solutions to an Intolerable Problem
  Medscape Education Ob/Gyn & Women's Health September 25, 2023
  When would you treat women for iron deficiency?
  
  0.50 CEMIN

  
  Save
• 10.25 90.25
  Metastatic HER2-Positive Breast Cancer Clinical Consult: Sequencing Therapies in Light of Progression
  Medscape Education Oncology September 21, 2023
  How do we treat patients who need beyond third-line treatment for metastatic HER2-positive breast cancer? Drs Mahtani and Hamilton discuss how to manage these patients.
  
  0.25 CMEMIN 0.25 ABIM MOCMIN

  
  Save
• 10.50 90.50
  Intermingling Genomics and Ovarian Cancer Treatment Decisions
  Medscape Education Oncology September 20, 2023
  Do you know which biomarkers can help you identify patients with advanced ovarian cancer (OC) who may benefit most from first-line maintenance with a poly(ADP-ribose) polymerase (PARP) inhibitor?
  
  0.50 CMEMIN 0.50 ABIM MOCMIN

  
  Save
• 11.00 91.00
  Clinical Overview of Oral Selective Estrogen Receptor Degraders
  Medscape Education Oncology September 20, 2023
  Do you know how to incorporate oral selective estrogen receptor degraders (SERDs) in patients with hormone receptor (HR)-positive advanced breast cancer?
  
  1.00 CMEMIN 1.00 ABIM MOCMIN

  
  Save